Clinical Symposium on Advances in Skin & Wound Care
Links shared publicly online about this topic.
- 1,003total visits
Clinical Symposium on Advances in Skin & Wound Care
View full resource at symposiumonwoundcare.com
Most Recently Shared on July 27, 2011 at 11:34 am By:
26th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing http://t.co/AEHYkte
Also Shared By:
Pollogen’s Advanced Apollo Anti-Aging System Now Available in Taiwan - Yahoo! News
news.yahoo.com — “From Yahoo! News: The Apollo System powered by TriPollar technology, a 3rd generation radiofrequency solution for facial and body contouring, has been approved for sale in Taiwan. TriPollar technology has been clinically proven to safely and effectively reduce wrinkles, tighten the skin, improve cellulite and scars, and decrease body fat and circumference.(PRWEB) March 07, 2012 Pollogen Ltd., a global leader in the medical aesthetics market, announced today that it has received regulatory approv” View full resource at news.yahoo.com
Most Recently Shared on March 7, 2012 at 8:25 am By:
Pollogen’s Advanced Apollo Anti-Aging System Now Available in Taiwan: The Apollo System powered by TriPollar tec... http://t.co/el90V3yU
How does Microdermabrasion Work? |La Jolla Cosmetic Laser Blog
lajollalaser.com — “How does Microdermabrasion Work? |La Jolla Cosmetic Laser Blog” View full resource at lajollalaser.com
Most Recently Shared on January 9, 2012 at 11:58 am By:
Nasrin Mani, M.D. is the founder of La Jolla Cosmetic Laser Clinic. Dr. Mani
has over 20 years experience with lasers in the precision surgical treatment of eye
conditions.
Since 2005 she has built a full scale aesthetic medical
clinic for facial and body improvements. Dr. Mani has become a trainer and
designated speaker for a wide variety of injectables...including
Allergan's Juvederm and Botox, Medicis' Restylane and Dysport, Merz'
Radiesse and Suneva Medical's Artefill.
As a Board Certified Ophthalmologist with subspecialty in vitreo-retinal
eye surgery, Dr. Mani incorporates years of expertise and skills in vitreo-retinal
surgeryin the establishment of a state-of-the-art cosmetic laser clinic.
Under Dr. Mani’s medical direction, clients are assured FDA safe and effective skin rejuvenation treatments and
medical-grade skincare products." /> Nasrin Mani, MD Physician, Active Health Library, Aesthetic Medicine, Doctor, and Ophthalmologist
UHN Nursing - Conferences
uhn.ca — “Nursing education is encouraged and supported at University Health Network in Toronto, Ontario. Professional Development Leaders facilitate and coordinate programs that are accessed by all nursing staff such as nursing orientation, mentorship and on-site courses. Advanced Practice Nurse Educators are based on one or more clinical units and their focus is on staff education specific to the clinical environment.” View full resource at uhn.ca
Most Recently Shared on December 8, 2011 at 9:15 pm By:
Scott Reeves Health Communicator and Science Enthusiast
Inaugural Patient-Centred Care Symposium, January 27, 2012: http://t.co/Ofodtvev #research #education #healthcare #interprofessional
OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies | Biomarker Commons
biomarkercommons.org — “OncoSec Medical Incorporated, which is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers, today announced it has entered into a collaborative research agreement with Serametrix Corporation to analyze subjects in three OncoSec Phase II clinical trials treating melanoma, Merkel cell carcinoma and cutaneous T-cel” View full resource at biomarkercommons.org
Most Recently Shared on November 17, 2011 at 4:34 pm By:
Vismodegib Shrinks Advanced Basal Cell Carcinoma : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on October 6, 2011 at 2:54 pm By:
Skin & Allergy News Health News
Vismodegib provided "substantial clinical benefit" for patients with BCC in phase II trial http://t.co/mLDhZBWC
AJMS Symposium Looks at Ethical Issues in Translational Research
newswise.com — “An important focus of medical research today is on translating new scientific discoveries into advances in clinical care that will lead to meaningful improvements in health outcomes. Ongoing ethical, legal, and social issues in this era of "translational" research are the subject of a special symposium in the October issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation. The journal is published by Lippincott W” View full resource at newswise.com
Most Recently Shared on September 29, 2011 at 3:04 pm By:
#health news: AJMS Symposium Looks at Ethical Issues in Translational Research: An important focus of medical re... http://t.co/dswIM02Z
$5 million Gift from John Gray Advances Melanoma Research at OHSU
ohsu.edu — “Longtime Oregon business leader and philanthropist John Gray has made a $5 million philanthropic investment that will advance melanoma research and clinical care at the OHSU Knight Cancer Institute. By supporting the institute’s search for new molecularly targeted melanoma therapies, the commitment reinforces OHSU’s pioneering role and ongoing leadership in the arena of personalized cancer medicine. Melanoma is regarded as the most dangerous form of skin cancer because of its ability to spread t” View full resource at ohsu.edu
Most Recently Shared on September 8, 2011 at 8:23 pm By:
OHSU Healthcare Healthcare System
Agreed. We're very appreciative of John Gray's gift. http://ow.ly/6pg8z RT @drghaheri: @OHSUHealthcare @OHSUNews wow
Biomedical and Health Informatics Leaders Convene to Present Innovative Science, Cutting-Edge Health Information Technologies
newswise.com — “Media registration is open for reporters who cover the hot new field in health care: informatics. AMIA Annual Symposium, Oct. 22-26, 2011, Washington, DC. The advance program for AMIA’s 35th Annual Symposium on Biomedical and Health Informatics previews a robust educational and scientific event of 15 themed tracks of content indluding natural language processing, security and privacy, data mining, consumer health and PHRs, policy and ethical issues, clinical education and global ehealth, to name” View full resource at newswise.com
Most Recently Shared on September 8, 2011 at 3:49 pm By:
#health news: Biomedical and Health Informatics Leaders Convene to Present Innovative Science, Cutting-Edge Heal... http://t.co/EuYnFDX
Biomedical and Health Informatics Leaders Convene to Present Innovative Science, Cutting-Edge Health Information Technologies
newswise.com — “Media registration is open for reporters who cover the hot new field in health care: informatics. AMIA Annual Symposium, Oct. 22-26, 2011, Washington, DC. The advance program for AMIA’s 35th Annual Symposium on Biomedical and Health Informatics previews a robust educational and scientific event of 15 themed tracks of content indluding natural language processing, security and privacy, data mining, consumer health and PHRs, policy and ethical issues, clinical education and global ehealth, to name” View full resource at newswise.com
Most Recently Shared on September 8, 2011 at 3:24 pm By:
newswise Health News and Health Communicator
Biomedical and Health Informatics Leaders Convene to Present Innovative Science, Cutting-Edge Health Information... http://t.co/0cPqs8c
Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011
news-medical.net — “Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.” View full resource at news-medical.net
Most Recently Shared on June 20, 2011 at 8:30 am By:
News-Medical.Net Oncology and Health News
Oncology News: Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011: C... http://bit.ly/k6leUy
Wound Care Professionals to Learn Latest Advances and Treatments, Pay Tribute to 9/11, at Clinical Symposium
newswise.com — “The 26th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 9-12, 2011, at the Gaylord National Hotel & Convention Center, National Harbor, MD. The symposium is sponsored by Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy. LWW is the publisher of the” View full resource at newswise.com
Most Recently Shared on June 6, 2011 at 3:42 pm By:
#health news: Wound Care Professionals to Learn Latest Advances and Treatments, Pay Tribute to 9/11, at Clinica... http://bit.ly/iMdMZH
Vaccine first to show improved survival rates for metastatic melanoma
labspaces.net — “For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.” View full resource at labspaces.net
Most Recently Shared on June 6, 2011 at 1:15 pm By:
Vaccine first to show improved survival rates for metastatic melanoma - http://is.gd/AR64mY
Survival Rates For Metastatic Melanoma Improve With Immune-boosting Interleukin-2 Vaccine
medicalnewstoday.com — “For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 ca” View full resource at medicalnewstoday.com
Most Recently Shared on June 5, 2011 at 7:05 am By:
Survival Rates For Metastatic Melanoma Improve With Immune-boosting Interleukin-2 Vaccine http://mnt.to/3WLG #skincancer #melanoma
Vaccine First To Show Improved Survival Rates For Metastatic Melanoma
medicalnewstoday.com — “For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 ca” View full resource at medicalnewstoday.com
Most Recently Shared on June 5, 2011 at 5:52 am By:
Vaccine First To Show Improved Survival Rates For Metastatic Melanoma: For patients with advanced melanoma, whic... http://bit.ly/j6MXa4
Melanoma vaccine shows promise in trial - USATODAY.com
yourlife.usatoday.com — “For patients with advanced melanoma, the most dangerous type of skin cancer, a vaccine combined with an immune-boosting drug is showing promise in a large clinical trial.” View full resource at yourlife.usatoday.com
Most Recently Shared on June 4, 2011 at 7:06 pm By:
Melanoma vaccine shows promise in trial http://usat.ly/iZ662g
Advertisement
Dr. Nancy Collins
@RD411
Sep 30-Oct 3 Gaylord Palms in Orlando - Clinical Symposium on Advances in Skin & Wound Care http://www.symposiumonwoundcare.com/
1 year ago...